VC Funds Starting with A

Anorak Ventures, founded in 2016 and headquartered in San Francisco, is a seed-stage venture firm that focuses on investing in transformative technology and people. The firm primarily invests in pre-seed and seed-stage companies across various technology sectors, including artificial intelligence and machine learning (AI/ML), Internet of Things (IoT), robotics, and consumer tech. Anorak Ventures has invested in over 120 seed-stage technology companies, which now represent an aggregate market capitalization of $24.8 billion. Notable investments in their portfolio include companies such as Vantage Point, WeatherCheck, Orderful, Framework, Prisms VR, Better Health, and Marxent. They are dedicated to helping these companies achieve product-market fit and secure follow-on financing. The firm, led by Managing Partner Greg Castle, aims to support innovative startups by providing not just capital but also strategic guidance to help them scale and succeed in competitive markets​.

ANRI is a venture capital firm based in Tokyo, Japan, focusing primarily on seed and early-stage investments. Founded with the mission to drive innovation, ANRI has invested in over 260 companies, emphasizing sectors such as electric vehicles, recycling, manufacturing, and information technology. Notable investments by ANRI include startups like Turing, a manufacturer in the electric vehicle sector, and amu, which focuses on recycling and waste management. Their portfolio showcases a strong commitment to diverse industries, including health tech and fintech. ANRI's investment approach often involves co-investing with other significant players in the market, thereby enhancing their portfolio companies' growth and market reach. ANRI has successfully achieved exits with companies like Raksul, DELY, and Coincheck, highlighting their capability to nurture startups towards profitable outcomes. Their investment philosophy emphasizes supporting innovative ideas that have the potential to make substantial impacts globally. The firm is also committed to diversity and inclusion, having set and achieved goals to increase investments in startups led by women. This dedication to fostering a diverse entrepreneurial ecosystem is part of ANRI's broader strategy to drive meaningful change and innovation in the startup landscape​.

Anterra Capital is a venture capital firm that specializes in investments within the food and agricultural technology sectors. Founded in 2013, Anterra Capital has offices in Amsterdam and Boston and focuses on backing innovative companies that address critical challenges in agriculture, food production, and sustainability. Their portfolio includes notable investments such as Enko Chem, which develops novel crop protection products; ProducePay, a financial and data services platform for the fresh produce industry; and BiomEdit, which focuses on microbiome innovation for animal health. The firm manages over $450 million in assets and typically invests in Series A or B rounds, with initial checks ranging from $1 to $10 million. Anterra is committed to leveraging biotechnology and digital solutions to transform the food system, improve consumer health, and enhance the livelihoods of farmers. Their investment strategy emphasizes impact and sustainability, aligning with their goal to create a resilient and sustainable food system. Anterra Capital has raised significant funds, including a $260 million second Global Food and Agriculture Technology Fund, which continues to support biotech and digital innovations in the agrifood sector​.

Anthem Venture Partners, founded in 2000 and based in Santa Monica, California, is a venture capital firm specializing in early-stage Series A and B investments. The firm primarily focuses on technology companies in Southern California, investing in sectors like software, internet, semiconductors, and new media​. Anthem typically invests between $1 million to $5 million in its portfolio companies and often takes a board seat, indicating a hands-on approach. The firm aims to be the first institutional investor, leading or co-leading the investments. Notable investments by Anthem Venture Partners include Surf Air, indie Semiconductor, Scopely, and Bird Global. The firm has a track record of successful exits, such as the IPO of Surf Air Mobility and the acquisition of Scopely by Savvy Games Group for $4.9 billion​. The team is led by founder and Managing General Partner William Woodward, along with partners like Claudia Llanos and Entrepreneur-in-Residence Sudhin Shahani. The firm's philosophy emphasizes building strong relationships with founders and taking a personal stake in the success of each investment​.

Anthemis Group, founded in 2010 and headquartered in London, is a global investment platform dedicated to fostering innovation in the financial system. The firm focuses on fintech, insurtech, and related sectors, investing from seed to growth stages. Anthemis' portfolio includes notable companies such as Betterment, eToro, and Currencycloud. They also back innovative startups like Pipe, Weavr, and Atomic. With over 150 investments worldwide, Anthemis emphasizes diversity and inclusivity, with 23% of their portfolio companies founded by women and 40% led by women or BIPOC. Their commitment to diversity is further demonstrated through the Female Innovators Lab, which supports female founders in fintech across the UK and Europe. Anthemis recently closed multiple funds totaling over $700 million, expanding their support for fintech companies throughout their lifecycle. The firm also launched an ESG-focused SPAC to advance sustainable finance. Anthemis' thesis-driven approach leverages deep market insights to drive systemic, long-term change. Led by founder Amy Nauiokas and CEO Briana van Strijp, Anthemis is poised to continue its mission of reinventing finance through innovation, collaboration, and inclusivity, supporting the next wave of fintech innovation globally.

Anthill Ventures is a venture capital firm that positions itself as a "speed-scaling" ecosystem, with a focus on helping early-stage startups grow rapidly across multiple sectors, including healthtech, mediatech, urban tech, and consumer tech. Based in Hyderabad, India, with additional offices in Singapore, Anthill provides much more than just capital; it connects startups with corporate partnerships, market access, mentorship, and infrastructure support to scale efficiently. Anthill invests in startups across India, the US, Europe, and Southeast Asia, particularly in sectors that are driving next-generation innovations. Their portfolio includes over 40 startups, ranging from media tech companies to healthcare platforms focused on early cancer detection and smart urban solutions. Some notable companies in their portfolio include Salud, Roadzen, and NAO Spirits. In addition to their core venture fund, Anthill operates several accelerators like Lumos Health and Indus-X, designed to scale companies in healthtech and urban tech, respectively. These programs help startups tap into business networks and expertise in both India and Singapore. Founded by Prasad Vanga, Anthill's team leverages strong international connections to guide startups through scaling challenges, driving impactful growth and fostering innovation across industries.

Anthos Capital, founded in 2007 and based in Santa Monica, California, focuses on growth-stage investments in consumer products, technology, healthcare, and financial services sectors. The firm has made notable investments in companies like Carbon Robotics, known for its Autonomous Weeder which helps reduce reliance on herbicides, and Todyl, a comprehensive cybersecurity platform aimed at small and mid-market businesses. Anthos Capital takes a strategic partnership approach, providing not just capital but also operational and strategic support to help portfolio companies grow and lead their industries. They focus on investments that promise significant growth and impact, supporting companies from early to growth stages with tailored assistance. The firm's recent investment activities include significant funding rounds for companies like Carbon Robotics and Todyl, reflecting their commitment to fostering innovation and industry leadership. Their portfolio showcases a diverse range of companies, emphasizing Anthos Capital's ability to identify and nurture high-potential ventures across various sectors.

Anthro Ventures is an early-stage venture capital firm focused on transforming healthcare and life sciences. The fund aims to improve patient outcomes while simultaneously reducing healthcare costs by investing in innovative, cutting-edge technologies. Anthro Ventures has made notable investments in companies such as Hannah Life Technologies and Ride Health, which align with their goal of addressing unmet clinical needs. Their investment strategy targets early-stage companies—primarily in pre-seed, seed, and Series A rounds. They focus on startups developing impactful medical devices, diagnostics, and digital health solutions. Geographically, their investments span both the U.S. and international markets, including regions like Singapore. Led by managing director Martin Akhavan, Anthro Ventures offers a hands-on approach, guiding their portfolio companies through growth and market dynamics. They tend to favor companies that present a clear path to scalability and that align with their mission of "humanizing healthcare." Startups looking to partner with Anthro should demonstrate both technological innovation and a strong potential to drive down healthcare costs.

Anti Fund, launched in 2021 by Jake Paul and Geoffrey Woo, is a venture capital firm breaking from traditional norms. With a focus on frontier technologies like AI, machine learning, blockchain, and digital health, the fund is built around the philosophy that capital alone isn’t enough—attention and cultural impact are equally critical. Anti Fund's investments include standout startups like Alchemy, Manifold, Osmind, and Moonpay. Based in Miami, the firm targets early-stage ventures, investing between $100,000 and $1 million per deal. Anti Fund primarily backs bold founders who can command attention and challenge industry paradigms. The team uses AngelList’s Rolling Fund model, allowing LPs to subscribe quarterly. Backed by prominent investors such as Marc Andreessen and Chris Dixon, the fund has gained quick traction. The fund’s strategy is centered on reshaping the cultural landscape, blending capital with the founders' ability to create significant market demand. This unique approach reflects both Paul’s background in entertainment and Woo’s expertise in tech entrepreneurship.

Antler is a globally renowned early-stage venture capital firm known as the "day zero investor," backing founders from the inception of their startups. With over 850 investments in 20+ countries, Antler has notable portfolio companies like Airalo, a global eSIM provider, and has recently raised a $60 million MENAP fund to further support startups in the Middle East, North Africa, and Pakistan region. Antler focuses on sectors including technology, fintech, and digital innovation, providing personalized coaching, co-founder matching, and follow-on funding. Key team members include Dr. Jonathan Doerr and Romain Assunção, leading regional activities from Riyadh and Duba

Anyon is a Germany-based venture capital firm focused on investing in early-stage technology companies that are digitizing the real estate industry. Established in 2016, Anyon operates with offices in Berlin, Frankfurt, and Munich. The firm primarily targets PropTech and IoT startups that aim to modernize real estate operations and management. Leveraging their expertise in real estate, Anyon partners with entrepreneurs to help them scale by offering strategic support, operational insights, and access to their network of industry experts. Anyon typically invests in pre-seed and seed-stage startups with ticket sizes ranging from €100k to €1.5 million. Their portfolio includes companies like Thing-it, an IoT platform for managing smart buildings, and Alasco, a construction management software designed to streamline financial processes in real estate projects. Anyon’s investment approach is deeply integrated with their platform, allowing startups to benefit from shared resources and technology infrastructure, driving value creation in their portfolio. The firm is led by founding partners Rupprecht Rittweger and Dr. Dennis Lips, who combine decades of experience in real estate and technology to guide the companies they back toward long-term growth and success.

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

AP Capital is a diversified investment firm with a strong presence in global markets, including equities, commodities, foreign exchange, and fixed income. Headquartered in Asia and Los Angeles, the firm specializes in proprietary trading and asset management. AP Capital aims to achieve consistent net-positive returns while minimizing market risks, making it a go-to choice for high-net-worth individuals, family offices, and institutional investors across Asia, Europe, and North America. The firm's investment strategy emphasizes a low correlation to broader market fluctuations, leveraging cutting-edge technology for its trading operations. AP Capital offers discretionary fund products and managed accounts, allowing investors greater transparency and control over their portfolios. Their diverse approach spans multiple industries, including real estate, renewable energy, and tech. With a focus on risk-adjusted returns and liquidity improvement, AP Capital has built a reputation for being nimble and adaptable, thanks to its young, energetic, and meritocratic team culture.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

Aperture Venture Capital (Aperture VC) is a venture capital firm founded in 2021, based in Radnor, Pennsylvania. The firm focuses on investing in early-stage companies, particularly those led by diverse founders who are building the future of fintech and enterprise software. Aperture VC's mission is to redefine the venture capital landscape by supporting the "Multicultural Mainstream," which includes Black, Latinx, and female entrepreneurs. Aperture VC’s unique approach involves its Diversity Investing API℠, a platform designed to connect corporate partners with diverse talent and market innovations. This platform also provides portfolio companies with critical operating resources to help them scale. The firm believes that by investing in diverse founders, they can unlock untapped potential and drive significant impact in the venture capital ecosystem. Aperture VC has quickly gained recognition in the industry, attracting investments from major corporations like PayPal, which have recognized the value of supporting diverse founders. The firm is committed to fostering an inclusive ecosystem where diverse entrepreneurs can thrive and achieve successful exits.

APEX Ventures is a venture capital firm based in Vienna, Austria, specializing in deep tech and medical technology startups. Founded in 2016, APEX Ventures invests in early-stage companies across Europe, with a focus on innovations in AI, quantum computing, automation, robotics, computer vision, space technology, and medical technology. The firm emphasizes backing startups with unique, defensible technologies that have the potential to disrupt and transform their respective industries​. In 2023, APEX Ventures partnered with Amadeus Capital Partners to launch the Amadeus APEX Technology Fund, which aims to raise €80 million to support deep tech startups primarily in the DACH region (Germany, Austria, and Switzerland). This fund focuses on seed and Series A investments, typically ranging from €1 million to €1.5 million. The partnership combines APEX’s local expertise and network with Amadeus’ extensive global experience in venture capital. APEX Ventures has a diverse portfolio, including companies like contextflow, ImageBiopsy Lab, and Mobius Labs. The firm is known for providing not just capital but also strategic support, leveraging their deep tech expertise and strong networks to help startups scale and succeed​.

Apollo Global Management, a leading global alternative investment manager, has a diverse and extensive portfolio across various sectors. As of 2024, Apollo manages approximately $548 billion in assets, with substantial investments in private equity, credit, and real estate. In the private equity space, Apollo's portfolio includes companies like ADT Inc., a major provider of security and automation solutions; CareerBuilder, an online employment service; and The Fresh Market, a specialty grocery retailer. They also have significant holdings in the healthcare sector with companies like LifePoint Health and R1 RCM Inc. Apollo is known for its strategic acquisitions across multiple industries. Notable recent acquisitions include U.S. Silica, a producer and supplier of silica sand, and Modern Aviation, a premium aviation services provider. Additionally, Apollo has made significant investments in the travel and hospitality sector, exemplified by its acquisition of Great Wolf Resorts and Diamond Resorts International. The firm's investment strategy focuses on creating value through buyouts, corporate carve-outs, and distressed asset investments. This approach has enabled Apollo to build a robust portfolio that spans various geographies, primarily the United States and the United Kingdom, with a strong presence in the energy and financial services sectors.

Apollo Projects, spearheaded by the Altman brothers—Sam, Jack, and Max—is a venture capital firm that specializes in funding transformative, early-stage companies. With a focus on "moonshots," Apollo targets startups with the potential to disrupt industries and create significant societal impact. Their portfolio boasts notable investments like KoBold Metals, which uses artificial intelligence for mineral exploration, and Glydways, a revolutionary transportation company. Apollo Projects is particularly active in sectors such as AI, renewable energy, and advanced biotechnology, where innovation can drive profound change. The firm typically leads funding rounds, writing substantial checks to support the ambitious goals of its portfolio companies. Apollo's investment strategy is centered around identifying and nurturing startups that are not only innovative but also have a clear vision for large-scale impact. They are especially interested in companies that challenge the status quo and push the boundaries of technology and industry norms. With a seasoned team led by the Altman brothers—each bringing a wealth of experience from their diverse backgrounds—Apollo Projects offers more than just capital. They provide strategic guidance and a deep network of industry connections, making them an invaluable partner for startups aiming to scale quickly and effectively. Entrepreneurs with bold, disruptive ideas often find Apollo Projects to be an ideal ally in their journey to bring groundbreaking technologies to market. This combination of financial backing, expertise, and a shared vision for the future positions Apollo Projects as a pivotal force in the venture capital landscape.

Apollo Health Ventures is a transatlantic venture capital firm with offices in Berlin and Boston, focusing on biotechnology and health tech ventures aimed at extending human healthspan. Established in 2016, Apollo specializes in seed and early-stage investments, particularly in companies that target aging-related diseases and conditions. Their investments focus on developing technologies and therapeutics that address the root causes of aging, helping to maintain cellular health, reduce chronic inflammation, and strengthen the immune system. In 2021, Apollo closed its second fund at $180 million, supported by both existing and new investors. This fund is designed to build and invest in data-driven companies developing breakthrough treatments for age-related diseases. Apollo has co-founded several pioneering companies, including Samsara Therapeutics, which develops autophagy-enhancing molecules, and Aeovian Pharmaceuticals, which focuses on therapeutics to extend healthspan. The firm is led by a team of experienced biotech investors and entrepreneurs, including co-founder Nils Regge, whose ventures have raised over $1 billion in capital. The team also includes Dr. Jens Eckstein, a seasoned venture capitalist with a history of successful biotech investments, and Dr. Marianne Mertens, who brings extensive experience from life sciences and venture investing. With its unique focus on longevity and aging-related innovation, Apollo Health Ventures is at the forefront of biotech ventures aiming to transform healthcare.

Appian Education Ventures is a global leader in building innovative, investor-backed educational enterprises. Founded by Luis García de Brigard, a former Deputy Minister of Education in Colombia, Appian is dedicated to transforming the education sector through cutting-edge solutions that foster sustainable and impactful learning environments. With offices in Boston, Miami, Madrid, Bogotá, and Abu Dhabi, the firm operates across a wide geographic footprint, reflecting its mission to expand access to quality education worldwide. Appian specializes in developing educational ventures that integrate technology and robust curricula, aiming to improve educational outcomes. Their approach includes partnering with educators, policymakers, and investors to create transformative learning models. With a focus on outcome-based innovations, Appian ensures that technological advancements in education are effectively implemented to foster academic success and personal growth. The firm's leadership brings decades of expertise from sectors like education, government, and business. Founder Luis García de Brigard has extensive experience in both public policy and educational entrepreneurship. Other key members include former consultants and executives from top firms like McKinsey & Company, Bain & Company, and Accenture, all of whom bring a wealth of strategic knowledge to the firm. This combination of educational insight and business acumen enables Appian to drive large-scale educational improvements globally. Through its ventures, Appian provides comprehensive services, including curriculum development, school management, and advisory support for educational technology. Its global reach and expert team make it a key player in reshaping education for the 21st century​.

Apple Tree Partners (ATP) is a distinguished venture capital firm focused on life sciences, founded in 1999 by Dr. Seth Harrison. With offices in New York, San Francisco, and Cambridge, ATP has committed $2.9 billion in capital, making it one of the key players in biotech venture investing. The firm’s approach is unique in that it both creates and invests in companies, often starting from early-stage scientific ideas or asset spinouts from other companies. ATP provides flexible capital and strategic support to foster the development of science-driven enterprises. The firm is involved in every stage of a company’s life cycle, from seed investments to IPO and beyond. Notably, ATP has been instrumental in launching over 30 life sciences companies, of which 19 have gone public or been acquired. Some successful portfolio companies include Chinook Therapeutics, Akero Therapeutics, and Stoke Therapeutics​. In addition to financial backing, ATP brings operational expertise to its portfolio companies, helping them navigate clinical trials, regulatory processes, and market entry strategies. The firm has pioneered advancements in fields such as oncology, metabolic diseases, and inflammatory disorders, combining deep scientific understanding with entrepreneurial rigor. ATP’s investments, including its recent creation of Deep Apple Therapeutics, exemplify its commitment to using cutting-edge technologies like AI and machine learning to accelerate drug discovery and deliver life-changing therapies.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

Apposite Capital is a London-based venture capital firm specializing in the healthcare sector. Founded in 2006, the firm focuses on investing in innovative healthcare companies across the UK and Europe. Apposite Capital provides a mix of venture, development, and growth financing, along with buyout capital, primarily targeting companies that can significantly impact healthcare through improved services and technologies. Their investment strategy emphasizes supporting companies with scalable business models and strong growth potential. Apposite Capital has a track record of successful investments in healthcare services, medical devices, diagnostics, and digital health. The firm typically takes an active role in its portfolio companies, providing strategic guidance and leveraging its extensive network within the healthcare industry to drive growth and innovation. Apposite Capital's team brings a combination of operational, scientific, and financial expertise, allowing them to deeply understand and support the unique needs of healthcare businesses. They also focus on promoting best practices in environmental, social, and governance (ESG) and are committed to making a positive impact through their investments. Recent notable investments include companies like NIMGenetics, HCML, and Emblation, showcasing their commitment to advancing healthcare solutions and improving patient outcomes​.

APX is a Berlin-based venture capital firm that focuses on pre-seed investments, supporting startups at the earliest stages. Founded in 2018 as a joint venture between Axel Springer and Porsche, APX is known for backing digital business models and exceptional founding teams across Europe. It has invested in over 185 companies, spanning industries such as fintech, SaaS, consumer services, and mobility. APX is committed to being a long-term partner, often serving as the first investor for many startups. They typically provide initial funding up to €500,000, with follow-on support available as companies grow. In 2023, they launched HEARTFELT, a new fund focused on continuing early-stage investments while managing their existing portfolio. With a hands-on approach, APX offers not just capital but also guidance on sales, operations, and strategic partnerships. Their network of experienced investors and successful entrepreneurs plays a key role in helping startups scale.

Aqua-Spark, based in the Netherlands, is a global investment fund dedicated to sustainable aquaculture. Founded in 2013 by Mike Velings and Amy Novogratz, the fund aims to transform the aquaculture industry by promoting environmental and social sustainability alongside financial returns. Aqua-Spark's mission is to make the production of aquatic life such as fish, shellfish, and plants safe, accessible, and environmentally friendly. The fund manages around $450 million in assets and has invested in 24 companies across the aquaculture value chain, aiming to expand its portfolio to 50-60 companies. Some notable investments include eFishery, an Indonesian aquaculture tech startup, Calysta, a biotech company producing sustainable feed ingredients, and Wanda Fish, which is developing cultivated bluefin tuna. Aqua-Spark focuses on early-stage investments, typically at the Series A stage, and supports companies through to maturity. Their investments are chosen for their potential to generate significant environmental and social impacts while delivering solid financial returns. The fund has a diverse investor base of around 300 investors from over 25 countries.

Aquarius Equity is a UK-based venture capital firm with a strong focus on early-stage investments in high-growth companies, particularly those located in the North of England. The firm, established to bridge the venture capital gap in this region, is dedicated to supporting innovative startups that have the potential to scale significantly. Their latest fund, the Aquarius Origin Fund, targets investments of up to £750,000, focusing on sectors like biotechnology, life sciences, and technology. Aquarius Equity's investment strategy emphasizes scalability and sustainability, with a particular interest in companies that align with the UN Sustainable Development Goals. They seek out companies with proven business models and significant growth potential, especially those that have already secured investment from industry-recognized investors. The firm also encourages investments from private individuals through Self Invested Personal Pension (SIPP) schemes, allowing them to invest in early-stage companies traditionally dominated by institutional funds. Aquarius Equity is not just a financial backer but also an active partner, providing strategic support to help startups achieve their growth ambitions. The firm’s commitment to innovation and sustainability positions it as a key player in the venture capital landscape, particularly in the UK’s underserved Northern regions.

Aquilo Capital Management is a biotech-focused investment firm based in San Francisco, established in 2010. The firm specializes in funding drug development companies that utilize cutting-edge science to address urgent medical needs. Aquilo’s approach is rooted in deep sector expertise and a disciplined, value-oriented investment strategy. They focus on identifying biotech companies with the potential to create transformative therapeutics that can significantly impact healthcare and society. The firm’s investment strategy is heavily concentrated in life sciences, targeting innovative drug discovery and development projects. They aim to balance risk with high potential returns, favoring companies that are on the cusp of delivering paradigm-shifting treatments. Aquilo employs both a long-only and hedged investment strategy, giving them flexibility and resilience in volatile markets. Notable investments include pioneering biotech firms like Arrowhead Pharmaceuticals and Regenxbio. Aquilo Capital is led by founder and CIO Marc Schneidman, who brings over 20 years of experience in the biotech investment space. The firm takes a global perspective, with a keen interest in leveraging opportunities in both the U.S. and Europe. They are known for supporting early-stage ventures and maintaining strong relationships with the scientific and biotech communities. Aquilo’s mission is to bridge the gap between groundbreaking science and successful commercial application, delivering both societal benefits and strong returns for investors.

marArali Ventures, founded in 2017 and based in Bangalore, India, is a venture capital firm focused on early-stage investments in enterprise tech startups. The firm primarily targets companies in India but has also invested in the United States and Singapore. Their investment strategy includes sectors such as artificial intelligence, fintech, healthtech, and high tech. Notable investments by Arali Ventures include Wingman, a conversational AI for sales, and Insent, a B2B enterprise sales platform acquired by ZoomInfo in 2021. Other significant investments include Protecto in business services and Wiz Freight in logistics tech​. Arali Ventures has made 28 investments to date and has achieved notable exits with companies like Insent and Wingman. The firm is currently raising its second seed fund, aiming for $30-40 million, to continue supporting startups in SME tech, industrial automation, and robotics​. Their team, led by Managing Partner Rajiv Raghunandan, provides extensive support to portfolio companies, emphasizing a hands-on approach and deep industry expertise. This supportive environment has made them a highly founder-friendly VC firm.

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, one of the world’s largest integrated energy and chemicals companies. Established in 2012, the fund has grown significantly, recently receiving an additional $4 billion, bringing its total capital to $7.5 billion. This expansion supports Aramco's long-term strategy of investing in technologies critical to energy transition and sustainability. Aramco Ventures operates through several specialized funds, including its Prosperity7 and Sustainability Fund, focusing on sectors such as carbon management, hydrogen, renewables, AI, and advanced materials. The firm has made over 140 investments globally, backing companies like Promethean Particles and Seeq that align with its strategic goals of advancing low-carbon and innovative technologies. The fund is headquartered in Dhahran, Saudi Arabia, and led by CEO Mahdi Aladel. It actively seeks out companies that can contribute to the global energy transition, emphasizing technologies that offer scalable solutions to the challenges facing the energy sector today​.

Aravis is a private equity firm based in Zurich, Switzerland, founded in 2001 by Jean-Philippe Tripet. The firm focuses on high-tech growth investments, primarily in the biotech, creative and digital, and industrial high-tech sectors. Aravis has sponsored multiple fund vintages and has deployed over USD 400 million across four funds. Aravis Growth I LP, their latest initiative, targets investments in established, innovative Swiss and European companies with significant growth potential. This fund aims to fill the gap in growth capital in the region by offering strategic advice, access to networks, and capital to accelerate companies through their growth phases​. The team at Aravis is composed of experienced professionals from various backgrounds, including finance, industry, and technology, providing a wealth of knowledge and expertise to support their portfolio companies. Their investment approach also integrates ESG criteria, aligning with several UN Sustainable Development Goals (SDGs).

ARAX Capital Partners, founded in 2007 and based in Vienna, Austria, is a venture capital firm that focuses on early-stage investments across the life sciences and technology sectors. They are particularly invested in Austrian ventures, targeting young, innovative companies, especially those with patentable technology. ARAX is committed to fostering the growth of startups in these fields by providing significant strategic and financial support. The firm's notable investments include Calyxha Biotechnologies, EveliQure Biotechnologies, and Panoptes Pharma, showcasing their emphasis on biotech and life sciences. Additionally, they have invested in technology companies like The MoonVision and crystalsol, a renewable energy company​​. ARAX Capital Partners generally participates in funding rounds ranging from $1 million to $9 million and has made 41 investments to date. They typically lead rounds, indicating their active role in shaping the growth trajectories of their portfolio companies​​. The team at ARAX is led by experienced partners such as Christian Tiringer, Beatrix Schuberth, and Thomas Cimbal, who bring extensive expertise in venture capital and entrepreneurship to the firm​​. This leadership helps ARAX maintain a strong network and high-quality deal flow, positioning them as a key player in Austria’s venture capital landscape. For startups, ARAX Capital Partners is a valuable partner, particularly for those in the early stages of development, looking for both capital and strategic guidance to scale their innovative solutions in the biotech and technology sectors​.

ARB Corporation Limited is an Australian company renowned for designing, manufacturing, and distributing 4x4 accessories. Their investments and acquisitions include a 30% stake in Orw USA, Inc. for $5 million and a 49% stake in Nacho LED, LLC for $2 million . These strategic investments aim to enhance ARB's market presence and product offerings in the automotive accessories sector.

Arboretum Ventures, headquartered in Ann Arbor, Michigan, is a prominent venture capital firm specializing in the healthcare sector. Founded in 2002 by Jan Garfinkle and Tim Petersen, the firm manages $1 billion across six funds. Arboretum Ventures focuses on capital-efficient investment opportunities in medical devices, life science tools, diagnostics, tech-enabled care delivery, and pharma adjacencies​. The firm has a strong commitment to investing in under-ventured geographies, particularly in the Midwest. Their portfolio includes a variety of innovative companies such as NeuMoDx, which was acquired by QIAGEN, and Fifth Eye, known for its early warning system for patient care​. Arboretum's investment strategy emphasizes supporting startups that aim to reduce healthcare costs while improving patient outcomes. They are active partners, providing strategic guidance and leveraging their extensive network to help portfolio companies succeed. The team includes managing partners Jan Garfinkle, Dr. Tom Shehab, Dan Kidle, and other key members like Paul McCreadie and Marcy Marshall. Overall, Arboretum Ventures stands out for its proactive involvement with entrepreneurs and its focus on transformative healthcare solutions that address significant industry challenges​,

Arborview Capital is a private equity firm headquartered in Chevy Chase, Maryland, founded in 2008. The firm focuses on investing in impact-driven, high-growth companies that contribute to sustainability and resource efficiency. With a deep commitment to environmental stewardship, Arborview seeks to back companies that drive positive change across industries like energy efficiency, sustainable agriculture, water conservation, and waste reduction. Their portfolio includes standout companies like Vital Farms, TemperPack, Rachio, and Copper Cow Coffee, all recognized for pushing the boundaries of sustainability and innovation. Arborview Capital typically invests between $5 million and $15 million, engaging with companies that generate at least $5 million in revenue and have a clear path to profitability. Their investment strategy is built around creating concentrated portfolios, allowing them to take a hands-on approach and form deep, strategic partnerships with management teams. They are open to leading rounds or co-investing, and often hold board positions, ensuring active involvement in scaling their companies. Geographically, Arborview primarily invests in U.S.-based companies, though they also explore opportunities in Canada and Mexico. As a B Corp certified firm, they align their financial goals with their commitment to creating lasting environmental impact, prioritizing patient capital over quick exits. Led by co-founders Joseph Lipscomb and Karl Khoury, alongside a seasoned team, Arborview prides itself on being a values-driven firm. Their approach combines deep industry expertise with a genuine passion for sustainability, making them trusted partners for entrepreneurs looking to scale impactful businesses.

Arc Ventures is a New York-based venture capital firm that connects founders with a global network of funds, advisors, and industry experts. Focused on fostering innovation, Arc Ventures operates as the venture arm of a single family office, originally part of Arc Group Holdings. The firm emphasizes long-term partnerships and operates across diverse geographies, including the U.S., Israel, and Europe, with plans to expand into Asia. Founded in 2019, Arc Ventures invests in both startups and venture funds, supporting entrepreneurs in sectors like fintech, health tech, digital media, and autonomous driving. Notable companies in their portfolio include Arbe Robotics, Alpha Tau, and Allure Security. The firm leverages its extensive network to introduce founders to potential customers, funding sources, and strategic partners, helping them scale quickly. The firm prides itself on a unique approach that blends data-driven insights with human connections, ensuring that promising ventures receive both financial backing and the mentorship needed to thrive.

Arch Venture Partners is a powerhouse in venture capital, specializing in early-stage investments in life sciences and technology. With a notable portfolio that includes industry leaders like Grail, Illumina, and Denali Therapeutics, Arch focuses on groundbreaking innovations that transform healthcare and biotech. They have a strong geographic footprint in the United States, with significant investments also in China and the UK. Their investment strategy centers on nurturing disruptive technologies with high-impact potential. Arch Venture Partners typically leads investment rounds, deploying substantial capital to accelerate growth, evidenced by their recent $2.975 billion Fund XII. The firm prioritizes deep scientific expertise and collaborates closely with founders to guide long-term strategic development. Average check sizes vary, but their robust funding capabilities mean they often make sizable commitments. Founded in 1986, Arch is driven by a team of seasoned professionals, including co-founder Robert Nelsen, who has been instrumental in the success of numerous billion-dollar companies. The firm values direct and collaborative approaches from startups, emphasizing the importance of innovative ideas backed by solid research. Overall, Arch Venture Partners stands out for its dedication to pioneering science and technology, its active role in funding and strategy, and its impressive track record of high-profile successes.

Archer Venture Capital is a Los Angeles-based firm that focuses on direct secondary investments, primary growth equity, and follow-on capital to support high-growth private companies. Founded in 2010, Archer works with startups to unlock value by providing liquidity solutions, helping to align the goals of stakeholders and promote long-term growth. The firm’s expertise spans sectors such as martech, adtech, enterprise SaaS, and data-driven AI technologies. Archer's portfolio includes notable companies like Grammarly, Credit Karma, Fetch, Sovrn, and Impact, all of which leverage advanced technology to drive innovation in their industries. Archer typically invests between $100,000 to $2 million, actively partnering with founders to provide both capital and strategic guidance as their companies scale toward category leadership. With over 75 years of combined experience, Archer has supported over 75 companies, driving significant exits for businesses like SquareTrade, PlaceIQ, and Yodlee. The firm’s approach is designed to mitigate risks while accelerating growth, ensuring successful outcomes for founders, shareholders, and employees alike.

Archerman Capital is a global growth equity investor founded in 2018 by Harry Archerman, a Harvard PhD graduate in Applied Physics. Headquartered in Boston, with additional offices in Hong Kong and Bangalore, the firm focuses on investments across TMT (Technology, Media, and Telecommunications), deep tech, and healthcare sectors. Archerman Capital operates at multiple stages, from early-stage to later-stage ventures, with an emphasis on backing world-class entrepreneurs and venture fund managers. The firm was originally known as Ab Initio Capital before rebranding in 2023 to reflect its evolving strategy. Archerman Capital has built a diverse portfolio of investments, including companies like SignalPlus, d-Matrix, and Boréas Technologies, focusing on cutting-edge technology solutions ranging from AI-powered trading systems to digital in-memory computing. Additionally, Archerman Capital manages venture funds, further extending its reach into innovative startups across global markets. With a strong presence in key regions like the U.S., Asia, and Europe, Archerman Capital continues to expand its influence in the venture capital space, supporting transformative companies and driving technological advancements worldwide.

Archetype is an early-stage venture capital firm based in New York City, specializing in the cryptocurrency and blockchain sectors. Established to accelerate the decentralized future, Archetype focuses on backing the next generation of crypto founders who are dedicated to creating entirely new markets and disrupting the status quo. The firm brings extensive experience in investing, engineering, operations, policy, and community-building to support innovative builders from the ground up. Archetype's notable investments include companies like Movement Labs, which develops blockchain infrastructure; Stack, a platform for secure digital asset storage; and Lagrange, which focuses on decentralized finance (DeFi) solutions. Other significant investments are in companies such as Ritual, a Web3 platform for content creators, and Socket, a developer of interoperability solutions for blockchain networks. The firm is led by a crypto-native team with diverse backgrounds, including investing, technology, and community engagement, ensuring that their portfolio companies receive comprehensive support. Archetype’s mission is to help founders go from concept to market, leveraging their unique expertise and extensive network to foster success in the decentralized technology landscape.

Archetype is an early-stage venture capital firm that focuses on accelerating the decentralized future, primarily backing startups in the Web3 and cryptocurrency space. Founded in 2021 and based in New York, Archetype is led by founder Ash Egan and a team of experienced professionals from the crypto, investing, and engineering worlds. The firm invests in seed-stage companies, with check sizes typically ranging from $1M to $3M. They also lead many of their funding rounds. Archetype is known for backing founders who are disrupting traditional industries by creating entirely new markets within the decentralized economy. The firm's portfolio includes standout names like Alchemy, Socket, and Mona, all of which focus on cutting-edge technologies in crypto infrastructure, blockchain development, and decentralized applications. Archetype’s investment philosophy is centered on supporting founders with deep technical expertise and a vision for decentralization. They are highly active in the U.S., with a particular focus on startups that bring innovation to financial services, infrastructure, and software development. The firm also provides strategic guidance, leveraging its team’s extensive network within the crypto ecosystem to help startups grow from concept to market-ready products. By combining their expertise in both technology and operations, Archetype positions itself as a critical partner for crypto founders looking to build and scale innovative projects in the decentralized world.

Archimed Group, founded in 2014 and headquartered in Lyon, France, is a leading private equity firm specializing in the healthcare sector. The firm manages around €8 billion in assets and is focused on investing in small to midsize companies across seven key healthcare sectors, including Biopharma, MedTech, and Healthcare IT. Archimed’s strategy involves acquiring majority stakes in companies and working closely with them to accelerate growth, drive innovation, and expand internationally. Archimed has a strong track record, with its funds consistently ranking in the top decile for performance. The firm’s latest fund, MED Platform II, closed at €3.5 billion in 2023, making it the largest healthcare-only private equity fund raised by a European-based firm. This fund is primarily focused on mid-cap companies in Europe and North America, aiming to support healthcare leaders in scaling their operations through strategic acquisitions and capacity expansions. Archimed’s commitment to impact investing is evident through its alignment with sustainable development goals and its EURÊKA Foundation, which supports healthcare-related charitable initiatives. The firm’s unique blend of financial, medical, and operational expertise positions it as a key player in the global healthcare investment landscape.

ArcTern Ventures, a Toronto-based venture capital firm with offices in San Francisco and Oslo, is dedicated to tackling climate change through investments in breakthrough technologies. Their focus areas include renewable energy, clean mobility, the circular economy, sustainable food and agriculture, and industrial decarbonization. They manage one of the world's largest dedicated climate tech funds, recently closing their oversubscribed $335 million Fund III​. ArcTern Ventures typically invests in early growth-stage companies that show significant potential for greenhouse gas emission reductions. Their strategy is to back companies with some commercial traction, aiming for those that can rapidly scale revenue and provide immediate climate impact. They often lead investment rounds, with initial checks ranging from $5 million to $10 million, and can commit up to $35 million per company, including follow-on support​. Notable investments by ArcTern Ventures include Clir Renewables, Flashfood, Hydrostor, and Terramera. These companies exemplify ArcTern’s commitment to sustainability and innovation across North America and Europe. The firm values deep research and collaboration, partnering with bold entrepreneurs to drive significant environmental impact.

Ardent Venture Partners is a Washington, D.C.-based venture capital firm founded in 2020 by Philip Bronner and Philip Herget. The firm focuses on early-stage investments, particularly in AI-native applications, vertical SaaS, and B2B fintech. Ardent has a reputation for backing disruptive startups that modernize traditional enterprise software and enable new financial technologies. Ardent's portfolio includes notable companies like Verituity, Method Financial, and Pickleheads. The firm is especially bullish on embedded finance, where software companies integrate financial services directly into their platforms, and sees tremendous opportunities in modernizing B2B payments and banking technologies. Ardent typically leads early-stage rounds and emphasizes hands-on operational support, drawing on the extensive entrepreneurial and investment experience of its partners​. The firm's geographic focus spans key U.S. tech hubs like Washington, D.C., and New York, with a commitment to supporting the digital transformation of industries heavily reliant on outdated systems.

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Argon Ventures, based in Cambridge, Massachusetts, is a pre-seed venture fund focusing on Intelligent Industry Solutions. Founded by Robert Mason and Andrew Feinberg in 2020, Argon Ventures targets early-stage investments in Big Data & Analytics, SaaS, and Software sectors. The firm leverages its deep operational expertise to support founders in building impactful global businesses. Notable investments include companies like EnFi, Cyvl.ai, and PeakMetrics, reflecting Argon's commitment to high-tech, data-driven solutions. Argon Ventures typically leads rounds with an average investment size of around $2M, showing a preference for hands-on engagement from the earliest stages. The firm has built a strong co-investor network, collaborating with prominent investors such as Techstars and Glasswing Ventures. Argon Ventures is characterized by its proactive support in areas like team building, product strategy, and market entry. The team, including seasoned professionals like Bob Mason, brings a combination of technical insight and business acumen, helping startups navigate their growth journeys effectively. With a robust portfolio and a strategic focus on innovative tech solutions, Argon Ventures positions itself as a key player in the venture capital landscape, fostering the next generation of transformative companies.

Argonautic Ventures is a Seattle-based venture capital firm with a focus on emerging industries, including blockchain, biotech, synthetic biology, agtech, and AI. Founded in 2016, the firm takes a thesis-driven approach, identifying disruptive technologies and supporting companies across multiple stages of growth - from early MVP phases to secondary market exits. Their portfolio spans several high-impact sectors, backing companies like Molecular Assemblies, a leader in DNA synthesis technology, and Procore, a SaaS solution transforming construction project management globally. With a presence in markets across Asia and North America, Argonautic's investments reflect their goal of driving technological change and societal value. Argonautic Ventures is particularly active in supporting startups that innovate within deep learning, AI, food tech, and blockchain, with a commitment to long-term partnerships. Their strategy includes providing operational support and leveraging their global connections to help portfolio companies scale. Key team members include Viken Douzdjian and Rita Chiu, both co-founders, bringing deep expertise in operational management and investment strategy​.

Arix Bioscience is a global venture capital firm based in London, specializing in biotechnology investments. Founded in 2016, Arix focuses on backing early-stage companies that are developing breakthrough treatments and technologies in the life sciences sector. Their investment strategy targets ventures from late pre-clinical to clinical stages, emphasizing a diversified portfolio to mitigate risks inherent in biotech investments​. The firm has built a robust portfolio that includes companies like Autolus, a developer of CAR-T cell therapies for cancer, and Disc Medicine, which focuses on treatments for hematologic diseases. Arix has also been involved in significant financing rounds, such as the $50 million Series B for Evommune and Ensoma, highlighting their role in advancing innovative biotech startups. Arix operates a permanent capital model, allowing it to support its portfolio companies through market fluctuations without being bound by strict exit timelines. This approach enables them to provide sustained support to their investments, which is critical in the high-risk, high-reward biotech sector.

Arkitekt Ventures is a New York-based venture capital firm focused on advancing human health through early-stage investments. Their portfolio emphasizes innovative healthcare solutions, including digital health platforms, biotech, and frontier technologies like neurotech, AI, and bioengineering. Notable recent investments include Sollis Health, Nanite, and Mural Health, with check sizes ranging from $3M to $15M. Arkitekt primarily invests in the U.S. but has also backed companies in the UK, maintaining a sector focus in healthtech, medical devices, and life sciences. Their strategy centers on pre-seed to Series A stages, preferring startups with groundbreaking approaches to healthcare delivery and precision medicine. They rarely lead rounds but frequently co-invest with prominent partners like Bessemer Venture Partners and Torch Capital. Led by managing director Enke Bashllari and partner Pavan Choksi, Arkitekt Ventures values long-term partnerships and tends to back visionary founders who are leveraging cutting-edge science. Their team prefers a data-driven, relationship-building approach, and startups seeking funding should ideally present transformative technologies with strong early traction.

Arkley Brinc VC is a venture capital firm based in Warsaw, Poland, that focuses on early-stage investments in hardware-enabled startups, particularly in IoT, MedTech, and smart manufacturing sectors. The firm was established as a joint initiative between Arkley, a European pioneer in hardware investments, and Brinc, a global accelerator known for its deep connections in China’s manufacturing hubs. This partnership allows Arkley Brinc to offer startups not only capital but also a wealth of resources for product development, manufacturing, and global distribution. With a fund size of $15 million, Arkley Brinc invests up to $1 million per company, supporting them from the prototype stage through to IPO. The firm’s investments are concentrated in Poland and across Europe, leveraging its strategic networks to help startups scale effectively. Arkley Brinc has a strong track record, with over 50 projects supported and several successful exits and IPOs. The firm’s team consists of serial entrepreneurs and finance professionals with extensive experience in launching and scaling technology businesses. The Arkley Launchpad program is another key initiative, offering a highly individualized acceleration program designed to raise successful funding rounds and drive operational success. This program is tailored to the specific needs of each startup, providing access to a network of partners in prototyping, manufacturing, sales, and investment.

Armilar Venture Partners is a leading venture capital firm based in Lisbon, Portugal, with a strong international presence. Since its founding in 2000, Armilar has focused on early-stage technology-based companies, particularly in sectors where data, digitization, and connectivity are central. Notable investments include OutSystems, Feedzai, and Vawlt, showcasing their commitment to companies driving digital transformation. Armilar specializes in deep-tech investments, supporting startups that leverage cutting-edge technology to address significant societal challenges. They have a hands-on approach, providing not only capital but also strategic guidance to help their portfolio companies scale effectively. Their investment strategy includes focusing on companies with strong intellectual property and significant market potential, often leading funding rounds to ensure their startups have the resources needed for success. Geographically, while Armilar has a strong focus on Portugal, they are open to investing globally, demonstrating flexibility in finding and supporting the best opportunities regardless of location. Their investment strategy is characterized by patience and long-term support, often leading funding rounds and staying engaged through critical growth phases. The firm has a notable team, including Joaquim Rodrigues, the founder, and managing partners like Nuno Leite and Pedro Santos. These leaders bring extensive experience and a deep understanding of both technology and market dynamics, ensuring they can provide valuable support to their portfolio companies.